45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,980
Insurances with rates
12
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-346382 | LUTETIUM LU 177 DOTATATE 370 MBQ/ML IV SOLN | $362,040 | $190,433 | — | — | 11 |
| RX-339056 | RADIUM RA 223 DICHLORIDE 30 MCCI/ML IV SOLN | $135,443 | $71,243 | — | — | 12 |
| RX-332269 | USTEKINUMAB 90 MG/ML SC SOSY | $121,227 | $63,765 | — | — | 11 |
| RX-373211 | OCRELIZUMAB-HYALURONIDASE-OCSQ 920-23000 MG-UT/23ML SC SOLN | $104,289 | $54,856 | — | — | 10 |
| RX-365419 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $101,873 | $53,585 | — | — | 12 |
| 335 | Peritoneal Adhesiolysis With McC | $88,957 | $46,791 | — | — | 7 |
| RX-313560 | IPILIMUMAB 200 MG/40ML IV SOLN | $88,724 | $46,669 | — | — | 12 |
| RX-350177 | TAGRAXOFUSP-ERZS 1000 MCG/ML IV SOLN | $81,076 | $42,646 | — | — | 12 |
| 653 | Major Bladder Procedures With McC | $78,784 | $41,440 | — | — | 7 |
| 289 | Acute And Subacute Endocarditis With Cc | $78,164 | $41,114 | — | — | 3 |
| RX-359644 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $69,732 | $36,679 | — | — | 12 |
| RX-430359644 | LONCASTUXIMAB TESIRINE-LPYL 10 MG/2ML IV (WET SOLR VIAL) | $69,732 | $36,679 | — | — | 12 |
| RX-255737 | PEGASPARGASE 750 UNIT/ML IJ SOLN | $67,635 | $35,576 | — | — | 12 |
| 331 | Major Small And Large Bowel Procedures Without Cc/McC | $61,136 | $32,158 | — | — | 7 |
| RX-344974 | INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR | $58,607 | $30,827 | — | — | 12 |
| RX-430344974 | INOTUZUMAB OZOGAMICIN 0.9 MG/3.6ML IV (WET SOLR VIAL) | $58,607 | $30,827 | — | — | 12 |
| 828 | Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.R. Procedures Without C | $52,387 | $27,555 | — | — | 7 |
| RX-343282 | OCRELIZUMAB 300 MG/10ML IV SOLN | $52,175 | $27,444 | — | — | 12 |
| 787 | Cesarean Section Without Sterilization With Cc | $51,810 | $27,252 | — | — | 7 |
| 522 | Hip Replacement With Principal Diagnosis Of Hip Fracture Without McC | $48,841 | $25,690 | — | — | 7 |
| RX-351870 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $47,408 | $24,937 | — | — | 12 |
| RX-430351870 | POLATUZUMAB VEDOTIN-PIIQ 140 MG/7ML IV (WET SOLR VIAL) | $47,408 | $24,937 | — | — | 12 |
| RX-366179 | MOSUNETUZUMAB-AXGB 30 MG/30ML IV SOLN | $46,535 | $24,477 | — | — | 12 |
| 570 | Skin Debridement With McC | $46,407 | $24,410 | — | — | 6 |
| RX-362065 | EFGARTIGIMOD ALFA-FCAB 400 MG/20ML IV SOLN | $45,643 | $24,008 | — | — | 12 |
| 469 | Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity With McC Or Total Ankle Repl | $45,386 | $23,873 | — | — | 7 |
| 417 | Laparoscopic Cholecystectomy Without C.D.E. With McC | $44,866 | $23,600 | — | — | 7 |
| 580 | Other Skin, Subcutaneous Tissue And Breast Procedures With Cc | $44,623 | $23,472 | — | — | 7 |
| 256 | Upper Limb And Toe Amputation For Circulatory System Disorders With Cc | $44,450 | $23,381 | — | — | 7 |
| 784 | Cesarean Section With Sterilization With Cc | $44,445 | $23,378 | — | — | 7 |
| 470 | Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity Without McC | $44,146 | $23,221 | — | — | 7 |
| 623 | Skin Grafts And Wound Debridement For Endocrine, Nutritional And Metabolic Disorders With Cc | $43,405 | $22,831 | — | — | 7 |
| 481 | Hip And Femur Procedures Except Major Joint With Cc | $42,735 | $22,479 | — | — | 7 |
| 934 | Full Thickness Burn Without Skin Graft Or Inhalation Injury | $42,445 | $22,326 | — | — | 7 |
| 157 | Dental And Oral Diseases With McC | $42,383 | $22,293 | — | — | 7 |
| 559 | Aftercare, Musculoskeletal System And Connective Tissue With McC | $42,216 | $22,206 | — | — | 6 |
| 786 | Cesarean Section Without Sterilization With McC | $41,359 | $21,755 | — | — | 7 |
| 783 | Cesarean Section With Sterilization With McC | $40,273 | $21,184 | — | — | 7 |
| RX-362809 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $37,813 | $19,890 | — | — | 12 |
| RX-313170 | PRALATREXATE 40 MG/2ML IV SOLN | $37,425 | $19,686 | — | — | 12 |
| RX-408401163 | TARLATAMAB-DLLE 10 MG/4.2ML IV (WET SOLR VIAL) | $37,140 | $19,536 | — | — | 12 |
| 785 | Cesarean Section With Sterilization Without Cc/McC | $36,821 | $19,368 | — | — | 7 |
| RX-332268 | USTEKINUMAB 45 MG/0.5ML SC SOSY | $36,791 | $19,352 | — | — | 11 |
| 416 | Cholecystectomy Except By Laparoscope Without C.D.E. Without Cc/McC | $36,478 | $19,187 | — | — | 7 |
| 788 | Cesarean Section Without Sterilization Without Cc/McC | $36,395 | $19,144 | — | — | 7 |
| RX-367032 | RETIFANLIMAB-DLWR 500 MG/20ML IV SOLN | $36,152 | $19,016 | — | — | 12 |
| 805 | Vaginal Delivery Without Sterilization Or D&C With McC | $34,514 | $18,154 | — | — | 7 |
| 166 | Other Respiratory System O.R. Procedures With McC | $34,287 | $18,035 | — | — | 7 |
| 433 | Cirrhosis And Alcoholic Hepatitis With Cc | $33,890 | $17,826 | — | — | 7 |
| RX-310263 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $33,346 | $17,540 | — | — | 12 |
Showing top 50 of 5,980 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.